Form D · Biotechnology

EternaTear, Inc.

Raleigh, NC · CIK 0001808948

Offering snapshot reported Dec 7, 2020 · SEC filing

Reported sold
$4.94M
Offering amount: $4.94M
Investors reported
45
Form D · investor count
Minimum accepted
$5K
Reported outside-investor minimum
First sale
Mar 21, 2020
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$2.47M$4.94MApr 9, 2020: $2,200,000.00Apr 9, 2020Dec 7, 2020: $4,936,206.00Dec 7, 2020

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$2,200,000 → $4,936,206
  • Reported investors17 → 45

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 7, 2020Amendment$4,936,206$2,736,206vs Apr 9, 202045SEC filing
Apr 9, 2020Initial$2,200,000No comparison17SEC filing

Offering details

Securities
Equity, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-364646

Source: Form D, filed Dec 7, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Kent Geer Executive
Diethart Reichardt Director, Executive
Timothy Willis Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
5650 Six Forks Road Suite 202
Raleigh, NC, 27609